2022 Bloomage Spring Biomaterial Forum Event was successfully held at Park Hyatt Aviara Resort in San Diego, California on March 26. The four-hour event featured sessions on the latest market trend, regulations, and clinical experiences for dermal fillers. As the event organizer, Bloomage Biotech introduced the newly developed product – Polydeoxyribonucleotide (PDRN), a rising star in the aesthetic field.
“We are excited to have our event in San Diego. This is the local forum for the first time that Bloomage USA hosts,” said Lois Lu, General Manager of Bloomage Biotechnology USA Inc. “Bloomage has had great success in the raw material business related to Sodium Hyaluronate. We have also launched many innovative products such as PDRN and Ectoine. The event should be very helpful for us to explore more business opportunities in those innovative products.”
Sessions presented at the Forum included the following topics;
- Global Aesthetic Market Trends Presented by Mr. Michael Moretti | CEO | Medical Insight, Inc.
- US Regulations on Dermal Filler Related Product Development Presented by Mr. Kwame Ulmer| Principal | Ulmer Ventures
- PDRN – a novel biomaterial, Presented by Blair Xu | Product Manager | Bloomage Biotech
- China Aesthetic Procedure Market and Clinical Experiences for Mesotherapy & Filler, Presented by Dr. Zhang Guirong | Director of Dermatology Department | Shanghai Jingkang Hospital
This forum not only shed some light on the recent trends and research in the industry but also helped build social connections with experts from Bloomage Biotech and professionals from pharmaceutical companies, research institutes, and clinics.
